DE602005000992D1 - Feste Arzneizubereitung enthaltend ein kristallines in 1,4-Stellungen substituiertes Piperidinderivat - Google Patents

Feste Arzneizubereitung enthaltend ein kristallines in 1,4-Stellungen substituiertes Piperidinderivat

Info

Publication number
DE602005000992D1
DE602005000992D1 DE602005000992T DE602005000992T DE602005000992D1 DE 602005000992 D1 DE602005000992 D1 DE 602005000992D1 DE 602005000992 T DE602005000992 T DE 602005000992T DE 602005000992 T DE602005000992 T DE 602005000992T DE 602005000992 D1 DE602005000992 D1 DE 602005000992D1
Authority
DE
Germany
Prior art keywords
crystalline
piperidine derivative
pharmaceutical preparation
preparation containing
solid pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005000992T
Other languages
English (en)
Inventor
Fernandez Roberto Duro
Mendoza Maria Del Carmen Nieto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Alter SA
Original Assignee
Laboratorios Alter SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Alter SA filed Critical Laboratorios Alter SA
Publication of DE602005000992D1 publication Critical patent/DE602005000992D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE602005000992T 2005-04-25 2005-04-25 Feste Arzneizubereitung enthaltend ein kristallines in 1,4-Stellungen substituiertes Piperidinderivat Active DE602005000992D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05380082A EP1716848B1 (de) 2005-04-25 2005-04-25 Feste Arzneizubereitung enthaltend ein kristallines in 1,4-Stellungen substituiertes Piperidinderivat

Publications (1)

Publication Number Publication Date
DE602005000992D1 true DE602005000992D1 (de) 2007-06-06

Family

ID=34980344

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005000992T Active DE602005000992D1 (de) 2005-04-25 2005-04-25 Feste Arzneizubereitung enthaltend ein kristallines in 1,4-Stellungen substituiertes Piperidinderivat

Country Status (5)

Country Link
EP (1) EP1716848B1 (de)
AT (1) ATE360414T1 (de)
DE (1) DE602005000992D1 (de)
ES (1) ES2285665T3 (de)
PT (1) PT1716848E (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE202011000756U1 (de) 2011-03-31 2011-10-12 Micro Labs Limited Ebastine, nicht-mikronisierte Ebastinepartikel und pharmazeutische Zusammensetzungen umfassend Ebastine
EP2589376B1 (de) 2011-11-01 2016-09-21 Inopharm Limited Im Mund zerfallende Zusammensetzung aus Anti-Histamin-Wirkstoffen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2684298B1 (fr) * 1991-12-03 1994-03-11 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.

Also Published As

Publication number Publication date
EP1716848B1 (de) 2007-04-25
EP1716848A1 (de) 2006-11-02
ES2285665T3 (es) 2007-11-16
PT1716848E (pt) 2007-07-24
ATE360414T1 (de) 2007-05-15

Similar Documents

Publication Publication Date Title
CA2867194C (en) Multi-functional ionic liquid compositions for overcoming polymorphism and imparting improved properties for active pharmaceutical, biological, nutritional, and energetic ingredients
WO2006000371A3 (en) Pyrimidine derivatives as 11beta-hsd1 inhibitors
NO20052683L (no) Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
IL192298A (en) Heterocyclic Compounds, Their Acceptable Salts, Pharmaceuticals Containing and Using Them
HRP20192302T1 (hr) Amorfni lerkanidipin hidroklorid
TW200738241A (en) Pyridazine derivatives
NZ705763A (en) Methods for the preparation of biologically active compounds in nanoparticulate form
ZA200802454B (en) Use of thienopyridone derivatives as AMPK activators and pharmaceutical compositions containing them
IL196775A (en) Annotations 4,2-Bis (3-Methyl-Morpholine-4-Yl) -7-Phenyl-Pyrido [3,2- d] Pyrimidine, Containing and Using Pharmaceuticals as Drugs and Drug Manufacturing
DE602005025977D1 (de) Kristalline form des ibandronat-natriums und herstellungsverfahren dafür
WO2006044362A3 (en) N-sulfonylpiperidine cannabinoid receptor 1 antagonists
IL174758A0 (en) Solid-state montelukast
IL164699A (en) Derivatives of diketohydrazine compounds and pharmaceutical compositions and medicaments containing the compounds as the active ingredient
NO20085087L (no) Nye heterocykliske forbindelser
NO20084853L (no) Forbindelser som er agonister av muscarinreseptorer og som kan vaere effektive i behandling av smerte, Alzheimers sykdom og/eller schizofreni
EP1619180A4 (de) Casr-antagonist
WO2007017331A3 (en) Immediate release therapeutic systems for improved oral absorption of 7- [ (e) -tert-butyloxyiminomethyl] camptothecin
SE9904413D0 (sv) Comminuted form
WO2004014868A8 (en) Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors
MX2009003169A (es) Derivados de sulfonamida.
TR200504890T1 (tr) Benipidin hidroklorür içeren farmasötik bileşim
DE602005000992D1 (de) Feste Arzneizubereitung enthaltend ein kristallines in 1,4-Stellungen substituiertes Piperidinderivat
ATE420118T1 (de) Biotinylierte hexadecasaccharide, pharmazeutische zusammensetzungen daraus und deren verwendung
WO2005123086A3 (en) Ziprasidone dosage form
WO2004062562A3 (en) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof

Legal Events

Date Code Title Description
8332 No legal effect for de